Summary and Typical Uses

Metformin is a commonly prescribed biguanide used as first-line pharmacotherapy for people with type 2 diabetes. It lowers fasting and post-meal glucose when combined with diet and exercise. Clinicians may use metformin alone or together with other blood glucose lowering agents such as insulin, sulfonylureas, SGLT2 inhibitors, DPP-4 inhibitors, or GLP-1 receptor agonists.

Some specialists also prescribe metformin off-label for conditions like polycystic ovary syndrome. Always follow the directions from your prescriber and verify the sections on Essential Safety Governance and Safeguards Notices of warning and Treatment lingering reactions and When to Act if you are new to the medicine.

How Metformin Acts

Metformin reduces blood glucose by several complementary the mechanism at works:

  • Decreasing hepatic glucose production.
  • Lowering glucose absorption from the gut.
  • Improving insulin sensitivity in peripheral tissues, especially muscle.

When taken by itself metformin rarely causes hypoglycaemia. The risk rises if you add insulin or a sulfonylurea, exercise vigorously, miss meals, or drink alcohol. For practical safety information summary, see Essential Safety Industrial Be advised and Safety measures.

Available Patterns and Abilities

In the UK there are several formulations available. Typical preparations include:

  • Modified-release tablets: commonly 500 mg, 750 mg or 1000 mg, useful to reduce stomach upset.
  • Immediate-release tablets: commonly 500 mg and 850 mg; some manufacturers supply 1000 mg options.

Because dosing frequency and release characteristics differ, do not swap between formulations or strengths without checking with your pharmacist or prescriber. If you need information about switching, consult the section Safe Use and Dosing Tips.

Safe Use and Dosing Tips

Follow your prescriber's schedule. Practical steps that help reduce side effect risks and improve adherence:

  • Take tablets with or straight after food to lessen gastrointestinal complaints.
  • Keep to consistent dosing times each day to maintain steady drug levels.
  • If you experience tummy upset, a clinician may start low and increase the dose gradually or suggest a modified-release product.
  • Do not stop the medicine suddenly without medical advice.

If you are unsure about timing with other medicines, talk to your GP, diabetes specialist nurse, or community pharmacist. For i did not take my doses, refer to the guidance in the packaging insert. Skipped Dose Guidance.

After a Dose omission: What to Do

If a dose is forgotten, take it when you remember unless it is almost time for your next scheduled dose. Do not take two pills at once to compensate for a missed tablet. If you are uncertain about what to do, contact your pharmacist or prescriber for personalised guidance offered.

Storage unit & Handling

Keep metformin in its original container when possible and store as follows:

  • Store at typical room temperatures, normally between 20 and 25 degrees C; short periods between 15 and 30 degrees C are acceptable.
  • Avoid excessive heat, moisture and direct sunlight; do not keep medicines in bathrooms.
  • Do not allow children or pets to reach this.

Cautionary Warning notices and Cautionary measures

There are important situations when metformin should be used with caution or avoided. Do not take metformin without clinical advice if any of these apply:

  • Known allergy to metformin or any excipient in the product.
  • Severe renal impairment. Typically metformin is not recommended if estimated GFR is below 30 mL/min/1.73 m2; careful review and dose adjustment are required when eGFR is 30 to 45 mL/min/1.73 m2.
  • Severe hepatic illness, heavy chronic alcohol use, or conditions that increase the risk of lactic acidosis.
  • Unstable cardiac status such as recent myocardial infarction, circulatory shock or decompensated heart failure.
  • Severe dehydration, significant infection, or low oxygen states.
  • Diabetic ketoacidosis, which needs urgent hospital treatment with insulin; metformin is not an appropriate therapy for ketoacidosis.
  • Planned radiological scans with iodinated contrast or major surgery; your clinician may advise a temporary pause of metformin.
  • People aged 80 years or older without recent renal testing should have kidney function checked preceding the start.

Other practical safety notices:

  • Limit alcohol intake while taking metformin because alcohol can increase the risk of lactic acidosis.
  • Some people feel dizzy. Avoid driving or using machinery until you are sure how metformin affects you.
  • If you combine metformin with insulin or a sulfonylurea, keep fast-acting carbohydrate to hand for possible hypoglycaemia.
  • Contact your healthcare team urgently for severe abdominal pain, unexplained breathlessness, ongoing vomiting, unusual muscle pain, or profound fatigue as these may be signs of lactic acidosis.

If you are pregnant, planning to become pregnant or breastfeeding, discuss risks and benefits with your prescriber so an informed choice is made for you and your baby.

Possible collateral effects and When to Act

Usual adverse reactions that tend to abate with time or dose changes:

  • Gastrointestinal symptoms such as diarrhoea, nausea, vomiting, bloating and wind.
  • Occasional i am suffering from a headache or a metallic taste in the mouth.

Seek urgent healthcare for serious reactions:

  • Signs of severe allergic reaction: widespread rash, swelling of the face or throat, or breathing difficulties.
  • Intense pain in the midsection, marked drowsiness, muscle weakness, rapid breathing, or an unusual sensation of cold or clamminess which could indicate lactic acidosis.
  • New or worsening chest pain, palpitations, or shortness of breath.

If peripheral effects persist or significantly interfere with daily life, speak to your GP, diabetes nurse or pharmacist about dose adjustment or changing formulation.

Health monitoring and Practical Checks

Typical tracking and monitoring of performance while taking metformin includes:

  • Renal function (eGFR) at baseline in conjunction with then periodically as advised.
  • HbA1c tests to monitor glucose control.
  • Other blood tests such as a full blood count if clinically indicated.

Always carry an up-to-date list of medications to appointments and inform all healthcare professionals, including dental teams, that you take metformin. Confirm with your clinician whether metformin should be paused before iodinated contrast scans or major operations. Inspect the file on a computer, there are memory and storage, each with a different role. information Personal keeping materials in storage ensures their availability for future operations. & Handling. For standard dosing guidelines see Safe Use and Dosing Tips.

Alternate Options and GBP Price Guide

If metformin is unsuitable or additional glucose lowering is needed, prescribers may consider several the alternative choice classes. Choice depends on individual factors such as cardiovascular and renal status, weight goals, hypoglycaemia risk and side effect profiles.

  • SGLT2 inhibitors (for example dapagliflozin, empagliflozin, canagliflozin): increase renal glucose excretion and some have proven heart and kidney benefits.
  • GLP-1 receptor agonists (for example semaglutide, liraglutide, dulaglutide): often injectable and associated with weight loss; oral semaglutide is available for some people.
  • DPP-4 inhibitors (for example sitagliptin, linagliptin): weight neutral, low hypoglycaemia risk.
  • Sulfonylureas (for example gliclazide, glimepiride): effective and generally low cost but with higher hypoglycaemia and weight gain risk.
  • Pioglitazone: improves insulin sensitivity but may cause fluid retention and other harmful bodily effects.
  • Insulin therapy: required for some people as the disease progresses or during acute illness.

Indicative private range of costs in the UK for GBP

The price fluctuates by brand, pack size, together with the pharmacy. Many patients on the NHS will pay according to national prescription rules or be exempt. The following are approximate private or retail ranges for comparison:

  • Generic metformin tablets (typical packs of 28-56): around 1 to 6 GBP; modified-release forms can cost a little more.
  • SGLT2 inhibitors: roughly 25 to 45 GBP per month.
  • DPP-4 inhibitors: roughly 20 to 35 GBP per month.
  • GLP-1 receptor agonists: widely variable, commonly 70 to 200+ GBP per month depending on agent and dose.
  • Sulfonylureas like gliclazide: typically 2 to 6 GBP per month.
  • Insulin and devices: a wide range, often between 20 and 80 GBP per month depending on type and device.

These estimates are for general comparison only. On the NHS a standard prescription charge in England may apply per item; prescriptions are generally free in Scotland, Wales and Northern Ireland. For the latest figures check NHS guidance or consult local dispensing chemists. For a quick comparison of options see Prices Guide UK.

Further Help and Contacts

For more information contact your GP, diabetes specialist nurse or community pharmacist. Do not share medicines that require a prescription with anyone. In an emergency, seek urgent medical help.

To report negative effects or suspected problems with a medicine use the MHRA Yellow Card scheme. For questions about prescription costs consult NHS resources for your home nation or speak directly to local pharmacies for up-to-date premium pricing and dispensing details.

Additional aspects about Metformin